Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17660947rdf:typepubmed:Citationlld:pubmed
pubmed-article:17660947lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:17660947lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17660947lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:17660947lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:17660947lifeskim:mentionsumls-concept:C0678222lld:lifeskim
pubmed-article:17660947lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:17660947lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:17660947pubmed:issue1-2lld:pubmed
pubmed-article:17660947pubmed:dateCreated2007-10-22lld:pubmed
pubmed-article:17660947pubmed:abstractText"Side population" (SP) cells, which pump out the fluorescent dye H33342 via the ABCG2 transporter, define a putative stem/progenitor cell population in the mammary gland. Breast cancer SP cells recently isolated from the MCF-7 cell line possess similar properties and may represent stem cell-like cancer cells. This study extends SP cell analysis to a broad panel of human breast cancer cell lines and investigates the expression of differentiation-associated markers in isolated cancer SP cells. Expression of ABCG2 was determined in 16 breast cancer cell lines by quantitative RT-PCR, Western blotting and immunohistochemistry. Subsequently, all cell lines were screened for the presence of SP cells. Human breast cancer cell lines commonly express ABCG2. ABCG2-immunoreactivity was clearly restricted to rare cancer cells in several cell lines including Cal-51. Analysis of H33342-labeled Cal-51 cells revealed a small fraction of putative SP cells accounting for one percent of all cells. The genuine nature of Cal-51 SP cells was unambiguously verified by demonstrating a 30-fold increased ABCG2-expression in isolated Cal-51 SP cells. During in vitro expansion, Cal-51 SP cells generated heterologous non-SP (NSP) cells and ABCG2-expression declined dramatically. In contrast, NSP cells failed to sustain proliferation. Freshly isolated Cal-51 SP cells also exhibited increased expression of Muc1 and CALLA. Noteworthy, non-malignant mammary epithelial SP cells lack these differentiation markers, highlighting fundamental differences between non-malignant and breast cancer-derived SP cells. In summary, we established Cal-51 SP cells as a novel in vitro model to study differential gene expression in breast cancer-derived SP and NSP cells.lld:pubmed
pubmed-article:17660947pubmed:languageenglld:pubmed
pubmed-article:17660947pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17660947pubmed:citationSubsetIMlld:pubmed
pubmed-article:17660947pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17660947pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17660947pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17660947pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17660947pubmed:statusMEDLINElld:pubmed
pubmed-article:17660947pubmed:monthDeclld:pubmed
pubmed-article:17660947pubmed:issn0300-8177lld:pubmed
pubmed-article:17660947pubmed:authorpubmed-author:LehmannUlrich...lld:pubmed
pubmed-article:17660947pubmed:authorpubmed-author:KreipeHansHlld:pubmed
pubmed-article:17660947pubmed:authorpubmed-author:von...lld:pubmed
pubmed-article:17660947pubmed:authorpubmed-author:ChristgenMatt...lld:pubmed
pubmed-article:17660947pubmed:authorpubmed-author:BallmaierMatt...lld:pubmed
pubmed-article:17660947pubmed:authorpubmed-author:BruchhardtHen...lld:pubmed
pubmed-article:17660947pubmed:issnTypePrintlld:pubmed
pubmed-article:17660947pubmed:volume306lld:pubmed
pubmed-article:17660947pubmed:ownerNLMlld:pubmed
pubmed-article:17660947pubmed:authorsCompleteYlld:pubmed
pubmed-article:17660947pubmed:pagination201-12lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:meshHeadingpubmed-meshheading:17660947...lld:pubmed
pubmed-article:17660947pubmed:year2007lld:pubmed
pubmed-article:17660947pubmed:articleTitleIdentification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line.lld:pubmed
pubmed-article:17660947pubmed:affiliationInstitute of Pathology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. Christgen.Matthias@MH-Hannover.delld:pubmed
pubmed-article:17660947pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17660947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17660947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17660947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17660947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17660947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17660947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17660947lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17660947lld:pubmed